These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18805692)

  • 21. Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs.
    Hollingsworth SA; Kelly B; Valant C; Michaelis JA; Mastromihalis O; Thompson G; Venkatakrishnan AJ; Hertig S; Scammells PJ; Sexton PM; Felder CC; Christopoulos A; Dror RO
    Nat Commun; 2019 Jul; 10(1):3289. PubMed ID: 31337749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators.
    Niswender CM; Lebois EP; Luo Q; Kim K; Muchalski H; Yin H; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5626-30. PubMed ID: 18793851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
    Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy.
    Wakeham MCL; Davie BJ; Chalmers DK; Christopoulos A; Capuano B; Valant C; Scammells PJ
    ACS Chem Neurosci; 2022 Jan; 13(1):97-111. PubMed ID: 34905693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.
    Thal DM; Sun B; Feng D; Nawaratne V; Leach K; Felder CC; Bures MG; Evans DA; Weis WI; Bachhawat P; Kobilka TS; Sexton PM; Kobilka BK; Christopoulos A
    Nature; 2016 Mar; 531(7594):335-40. PubMed ID: 26958838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M
    Spearing PK; Cho HP; Luscombe VB; Blobaum AL; Boutaud O; Engers DW; Rodriguez AL; Niswender CM; Jeffrey Conn P; Lindsley CW; Bender AM
    Bioorg Med Chem Lett; 2021 Sep; 47():128193. PubMed ID: 34118412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The existence of a second allosteric site on the M1 muscarinic acetylcholine receptor and its implications for drug design.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1217-20. PubMed ID: 16364641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.
    Parihar HS; Suryanarayanan A; Ma C; Joshi P; Venkataraman P; Schulte MK; Kirschbaum KS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2133-6. PubMed ID: 11514154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators.
    Zhang L; Rogers BN; Duplantier AJ; McHardy SF; Efremov I; Berke H; Qian W; Zhang AQ; Maklad N; Candler J; Doran AC; Lazzaro JT; Ganong AH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5493-6. PubMed ID: 18812259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacologic characterization of allosteric molecules: Gq protein activation.
    Bdioui S; Verdi J; Pierre N; Trinquet E; Roux T; Kenakin T
    J Recept Signal Transduct Res; 2019 Apr; 39(2):106-113. PubMed ID: 31322035
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.
    Miller NR; Daniels RN; Lee D; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2174-7. PubMed ID: 20202841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective synthesis of oxazolidinonyl-fused piperidines of interest as selective muscarinic (M1) receptor agonists: a novel M1 allosteric modulator.
    Broadley KJ; Buffat MG; Burnell E; Davies RH; Moreau X; Snee S; Thomas EJ
    Org Biomol Chem; 2016 Feb; 14(6):2057-89. PubMed ID: 26768599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
    Ma L; Seager MA; Wittmann M; Jacobson M; Bickel D; Burno M; Jones K; Graufelds VK; Xu G; Pearson M; McCampbell A; Gaspar R; Shughrue P; Danziger A; Regan C; Flick R; Pascarella D; Garson S; Doran S; Kreatsoulas C; Veng L; Lindsley CW; Shipe W; Kuduk S; Sur C; Kinney G; Seabrook GR; Ray WJ
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15950-5. PubMed ID: 19717450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
    Keller M; Tränkle C; She X; Pegoli A; Bernhardt G; Buschauer A; Read RW
    Bioorg Med Chem; 2015 Jul; 23(14):3970-90. PubMed ID: 25650309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.
    Daval SB; Valant C; Bonnet D; Kellenberger E; Hibert M; Galzi JL; Ilien B
    J Med Chem; 2012 Mar; 55(5):2125-43. PubMed ID: 22329602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer's disease.
    Chintamaneni PK; Krishnamurthy PT; Rao PV; Pindiprolu SS
    Med Hypotheses; 2017 Apr; 101():17-22. PubMed ID: 28351483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs).
    Kuduk SD; Beshore DC
    Curr Top Med Chem; 2014; 14(15):1738-54. PubMed ID: 25176125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.
    Wang Y; Chackalamannil S; Hu Z; Clader JW; Greenlee W; Billard W; Binch H; Crosby G; Ruperto V; Duffy RA; McQuade R; Lachowicz JE
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2247-50. PubMed ID: 11055330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity.
    Sur C; Mallorga PJ; Wittmann M; Jacobson MA; Pascarella D; Williams JB; Brandish PE; Pettibone DJ; Scolnick EM; Conn PJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13674-9. PubMed ID: 14595031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor.
    Mistry SN; Jörg M; Lim H; Vinh NB; Sexton PM; Capuano B; Christopoulos A; Lane JR; Scammells PJ
    J Med Chem; 2016 Jan; 59(1):388-409. PubMed ID: 26624844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.